等待開盤 10-30 09:30:00 美东时间
-0.070
-0.48%
BiomX addressed FDA queries on the third-party nebulizer for BX004 and received encouraging feedback outlining potential development strategies for Phase 3. European enrollment and dosing remain strong, with the Phase 2b trial on track to report results in Q1 2026. The FDA recognized the significant unmet need for therapies targeting chronic *P. aeruginosa* infections in CF patients, offering pathways to refine study design. BiomX plans to incorp...
10-17 12:30
Nuveen S&P 500 Buy-Write Income Fund (NYSE:BXMX) declares $0.2725/share quarterly dividend, in line with previous. Forward yield 8.07% Payable July 1; for shareholders of record June 13; ex-div June 1...
06-03 21:10
2023年第1批市抽共抽查肥料产品101批次,其中流通领域化肥100批次,生产领域尿素1批次。 本次抽查依据NY/T 525-2021《有机肥料》、GB/T ...
2023-12-26 14:49
Nuveen S&P 500 Buy-Write Income Fund (NYSE:BXMX – Get Rating) announced a q...
2023-03-13 21:20
Nuveen S&P 500 Buy-Write Income Fund (NYSE:BXMX – Get Rating) saw a signifi...
2023-03-13 17:45
中国质量新闻网讯 近日,山东省滨州市市场监管局公布2022年复混肥料(含缓控释肥)产品质量市级监督抽查结果。本次抽检50批次复混肥料(含缓控释肥)产品,2批次不...
2022-12-08 12:26
Nuveen S&P 500 Buy-Write Income Fund (NYSE:BXMX – Get Rating) was the recip...
2022-08-05 14:31
SEE Ex-Dividend Reminder - 12/5/19 By Dividend Channel Staff, Tuesday, Decembe...
2021-07-13 00:11
Kosmos Energy (KOS) Passes Through 3% Yield Mark By Dividend Channel Staff, Th...
2021-07-13 00:11
Texas Capital Bancshares (TCBI) Shares Cross Above 200 DMA By Market News Vide...
2021-07-13 00:11